메뉴 건너뛰기




Volumn 18, Issue 5, 2010, Pages 499-509

Germline Brca2 Heterozygosity Promotes KrasG12D -Driven carcinogenesis in a murine model of familial pancreatic cancer

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; CRE RECOMBINASE;

EID: 78249247414     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2010.10.015     Document Type: Article
Times cited : (147)

References (45)
  • 1
    • 77955039099 scopus 로고    scopus 로고
    • Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
    • Audeh M.W., Carmichael J., Penson R.T., Friedlander M., Powell B., Bell-McGuinn K.M., Scott C., Weitzel J.N., Oaknin A., Loman N., et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 2010, 376:245-251.
    • (2010) Lancet , vol.376 , pp. 245-251
    • Audeh, M.W.1    Carmichael, J.2    Penson, R.T.3    Friedlander, M.4    Powell, B.5    Bell-McGuinn, K.M.6    Scott, C.7    Weitzel, J.N.8    Oaknin, A.9    Loman, N.10
  • 2
    • 67649881097 scopus 로고    scopus 로고
    • The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry
    • Ayoub N., Rajendra E., Su X., Jeyasekharan A.D., Mahen R., Venkitaraman A.R. The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry. Curr. Biol. 2009, 19:1075-1085.
    • (2009) Curr. Biol. , vol.19 , pp. 1075-1085
    • Ayoub, N.1    Rajendra, E.2    Su, X.3    Jeyasekharan, A.D.4    Mahen, R.5    Venkitaraman, A.R.6
  • 3
    • 0033523268 scopus 로고    scopus 로고
    • The Breast Cancer Linkage Consortium: cancer risks in BRCA2 mutation carriers
    • Breast Cancer Linkage Consortium T
    • The Breast Cancer Linkage Consortium: cancer risks in BRCA2 mutation carriers. J. Natl. Cancer Inst. 1999, 91:1310-1316. Breast Cancer Linkage Consortium T.
    • (1999) J. Natl. Cancer Inst. , vol.91 , pp. 1310-1316
  • 5
    • 0029125820 scopus 로고
    • K-ras mutation and pancreatic adenocarcinoma
    • Caldas C., Kern S.E. K-ras mutation and pancreatic adenocarcinoma. Int. J. Pancreatol. 1995, 18:1-6.
    • (1995) Int. J. Pancreatol. , vol.18 , pp. 1-6
    • Caldas, C.1    Kern, S.E.2
  • 6
    • 0032574733 scopus 로고    scopus 로고
    • The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment
    • Chen P.L., Chen C.F., Chen Y., Xiao J., Sharp Z.D., Lee W.H. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl. Acad. Sci. USA 1998, 95:5287-5292.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 5287-5292
    • Chen, P.L.1    Chen, C.F.2    Chen, Y.3    Xiao, J.4    Sharp, Z.D.5    Lee, W.H.6
  • 9
    • 33749007676 scopus 로고    scopus 로고
    • Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
    • Evers B., Jonkers J. Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene 2006, 25:5885-5897.
    • (2006) Oncogene , vol.25 , pp. 5885-5897
    • Evers, B.1    Jonkers, J.2
  • 15
    • 0034090681 scopus 로고    scopus 로고
    • High-thoroughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR
    • Germer S., Holland M.J., Higuchi R. High-thoroughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res. 2000, 10:258-266.
    • (2000) Genome Res. , vol.10 , pp. 258-266
    • Germer, S.1    Holland, M.J.2    Higuchi, R.3
  • 17
    • 0033842724 scopus 로고    scopus 로고
    • BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications
    • Goggins M., Hruban R.H., Kern S.E. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am. J. Pathol. 2000, 156:1767-1771.
    • (2000) Am. J. Pathol. , vol.156 , pp. 1767-1771
    • Goggins, M.1    Hruban, R.H.2    Kern, S.E.3
  • 24
    • 33751207530 scopus 로고    scopus 로고
    • American Registry of Pathology, Annapolis Junction, MD, AFIP ATLAS of Tumour Pathology, Series
    • Hruban R., Pitman M., Klimstra D.S. Tumors of the Pancreas 2007, AFIP ATLAS of Tumour Pathology, Series IV. American Registry of Pathology, Annapolis Junction, MD.
    • (2007) Tumors of the Pancreas , vol.4
    • Hruban, R.1    Pitman, M.2    Klimstra, D.S.3
  • 26
    • 0035734285 scopus 로고    scopus 로고
    • Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
    • Jonkers J., Meuwissen R., van der Gulden H., Peterse H., van der Valk M., Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 2001, 29:418-425.
    • (2001) Nat. Genet. , vol.29 , pp. 418-425
    • Jonkers, J.1    Meuwissen, R.2    van der Gulden, H.3    Peterse, H.4    van der Valk, M.5    Berns, A.6
  • 28
    • 0015043748 scopus 로고
    • Mutation and cancer: statistical study of retinoblastoma
    • Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 1971, 68:820-823.
    • (1971) Proc. Natl. Acad. Sci. USA , vol.68 , pp. 820-823
    • Knudson, A.G.1
  • 29
    • 0030924656 scopus 로고    scopus 로고
    • Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos
    • Ludwig T., Chapman D.L., Papaioannou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 1997, 11:1226-1241.
    • (1997) Genes Dev. , vol.11 , pp. 1226-1241
    • Ludwig, T.1    Chapman, D.L.2    Papaioannou, V.E.3    Efstratiadis, A.4
  • 35
    • 33744525857 scopus 로고    scopus 로고
    • Physiological analysis of oncogenic K-ras
    • Perez-Mancera P.A., Tuveson D.A. Physiological analysis of oncogenic K-ras. Methods Enzymol. 2006, 407:676-690.
    • (2006) Methods Enzymol. , vol.407 , pp. 676-690
    • Perez-Mancera, P.A.1    Tuveson, D.A.2
  • 36
    • 0028308492 scopus 로고
    • P53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions
    • Redston M.S., Caldas C., Seymour A.B., Hruban R.H., da Costa L., Yeo C.J., Kern S.E. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res. 1994, 54:3025-3033.
    • (1994) Cancer Res. , vol.54 , pp. 3025-3033
    • Redston, M.S.1    Caldas, C.2    Seymour, A.B.3    Hruban, R.H.4    da Costa, L.5    Yeo, C.J.6    Kern, S.E.7
  • 37
    • 0035813127 scopus 로고    scopus 로고
    • Analysis of murine Brca2 reveals conservation of protein-protein interactions but differences in nuclear localization signals
    • Sarkisian C.J., Master S.R., Huber L.J., Ha S.I., Chodosh L.A. Analysis of murine Brca2 reveals conservation of protein-protein interactions but differences in nuclear localization signals. J. Biol. Chem. 2001, 276:37640-37648.
    • (2001) J. Biol. Chem. , vol.276 , pp. 37640-37648
    • Sarkisian, C.J.1    Master, S.R.2    Huber, L.J.3    Ha, S.I.4    Chodosh, L.A.5
  • 41
    • 77955019276 scopus 로고    scopus 로고
    • Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
    • Tutt A., Robson M., Garber J.E., Domchek S.M., Audeh M.W., Weitzel J.N., Friedlander M., Arun B., Loman N., Schmutzler R.K., et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 2010, 376:235-244.
    • (2010) Lancet , vol.376 , pp. 235-244
    • Tutt, A.1    Robson, M.2    Garber, J.E.3    Domchek, S.M.4    Audeh, M.W.5    Weitzel, J.N.6    Friedlander, M.7    Arun, B.8    Loman, N.9    Schmutzler, R.K.10
  • 43
    • 63049108452 scopus 로고    scopus 로고
    • Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment
    • Venkitaraman A.R. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu. Rev. Pathol. 2009, 4:461-487.
    • (2009) Annu. Rev. Pathol. , vol.4 , pp. 461-487
    • Venkitaraman, A.R.1
  • 44
    • 0031466027 scopus 로고    scopus 로고
    • RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2
    • Wong A.K., Pero R., Ormonde P.A., Tavtigian S.V., Bartel P.L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 1997, 272:31941-31944.
    • (1997) J. Biol. Chem. , vol.272 , pp. 31941-31944
    • Wong, A.K.1    Pero, R.2    Ormonde, P.A.3    Tavtigian, S.V.4    Bartel, P.L.5
  • 45
    • 0033179235 scopus 로고    scopus 로고
    • BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo
    • Yuan S.S., Lee S.Y., Chen G., Song M., Tomlinson G.E., Lee E.Y. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res. 1999, 59:3547-3551.
    • (1999) Cancer Res. , vol.59 , pp. 3547-3551
    • Yuan, S.S.1    Lee, S.Y.2    Chen, G.3    Song, M.4    Tomlinson, G.E.5    Lee, E.Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.